Literature DB >> 25458861

Prolonged cortical silent period among drug-naive subjects at ultra-high risk of psychosis.

Yingying Tang1, Tianhong Zhang1, Bradley Edelman2, Botao Zeng3, Shanshan Zhao4, Chunyan Li4, Kaiming Zhuo3, Zhenying Qian4, Hui Li4, Qian Guo4, Huiru Cui4, Yikang Zhu4, Lijuan Jiang4, Chunbo Li1, Dehua Yu5, Jijun Wang6.   

Abstract

BACKGROUND: Deficits in gamma-aminobutyric acid (GABA) inhibitory neurotransmission have been associated with pathophysiological mechanisms underlying schizophrenia. However, little is known about whether these deficits occur before or after the onset of psychosis.
METHOD: We recruited 16 drug-naive subjects at ultra-high risk of psychosis (UHR), 17 schizophrenia patients and 28 healthy controls. Cortical inhibition was determined using transcranial magnetic stimulation (TMS) over the left primary motor cortex. TMS markers such as short-interval cortical inhibition (SICI), cortical silent period (CSP) and intracortical facilitation (ICF) were obtained from each subject. While SICI can reflect GABA type A (GABAA) mediated inhibition, CSP is thought to indicate GABA type B (GABAB) mediated inhibitory circuits.
RESULTS: As compared with healthy controls, UHR subjects showed a prolonged CSP with no change in SICI, whereas schizophrenia patients demonstrated both a prolonged CSP and a reduced SICI. No group differences were found for ICF. CSP in schizophrenia patients also had a positive correlation with positive symptom score of the positive and negative symptom scale (PANSS).
CONCLUSIONS: Cortical inhibitory deficits among UHR subjects were relatively limited compared to those among schizophrenia patients. Alterations might occur in some subgroup of GABA-mediated neurotransmitter systems before the onset of psychosis, while alterations in both GABAA and GABAB networks might contribute to full-blown psychosis.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cortical inhibition; Cortical silent period; Schizophrenia; Short-interval cortical inhibition; Ultra-high risk of psychosis

Mesh:

Year:  2014        PMID: 25458861     DOI: 10.1016/j.schres.2014.10.004

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  6 in total

1.  Altered Motor-Striatal Plasticity and Cortical Functioning in Patients with Schizophrenia.

Authors:  Dongsheng Zhou; Feng Pang; Shiyan Liu; Ying Shen; Lingjiang Liu; Zezhong Fang; Chuang Wang; Zhenyu Hu; Ti-Fei Yuan
Journal:  Neurosci Bull       Date:  2016-11-12       Impact factor: 5.203

2.  The role of white matter microstructure in inhibitory deficits in patients with schizophrenia.

Authors:  Xiaoming Du; Peter Kochunov; Ann Summerfelt; Joshua Chiappelli; Fow-Sen Choa; L Elliot Hong
Journal:  Brain Stimul       Date:  2016-11-12       Impact factor: 8.955

3.  A systematic review of TMS and neurophysiological biometrics in patients with schizophrenia.

Authors:  Meng di Hou; Viviana Santoro; Andrea Biondi; Sukhi S Shergill; Isabella Premoli
Journal:  J Psychiatry Neurosci       Date:  2021-12-21       Impact factor: 6.186

4.  Reduced γ-Aminobutyric Acid and Glutamate+Glutamine Levels in Drug-Naïve Patients with First-Episode Schizophrenia but Not in Those at Ultrahigh Risk.

Authors:  Junjie Wang; Yingying Tang; Tianhong Zhang; Huiru Cui; Lihua Xu; Botao Zeng; Yu Li; Gaiying Li; Chunbo Li; Hui Liu; Zheng Lu; Jianye Zhang; Jijun Wang
Journal:  Neural Plast       Date:  2016-11-28       Impact factor: 3.599

Review 5.  Assessment of Cortical Plasticity in Schizophrenia by Transcranial Magnetic Stimulation.

Authors:  Turki Abualait; Sultan Alzahrani; Ahmed AlOthman; Fahad Abdulah Alhargan; Nouf Altwaijri; Rooa Khallaf; Eman Nasim; Shahid Bashir
Journal:  Neural Plast       Date:  2021-12-02       Impact factor: 3.599

6.  Clozapine Prolongs Cortical Silent Period in Patients with Treatment-Resistant Schizophrenia.

Authors:  Atsuhiro Miyazawa; Nobuhisa Kanahara; Yusuke Nakata; Satoshi Kodama; Hiroshi Kimura; Atsushi Kimura; Yasunori Oda; Hiroyuki Watanabe; Masaomi Iyo
Journal:  Psychopharmacol Bull       Date:  2021-03-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.